Use of Persuasive Language in Communication of Risk during Prostate Cancer Treatment Consultations

Author:

Naser-Tavakolian Aurash1ORCID,Gale Rebecca2,Luu Michael3,Masterson John M.1,Venkataramana Abhishek4,Khodyakov Dmitry5ORCID,Anger Jennifer T.6,Posadas Edwin7,Sandler Howard8,Freedland Stephen J.19,Spiegel Brennan210,Daskivich Timothy J.12

Affiliation:

1. Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA

2. Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA, USA

3. Department of Biostatistics, Cedars-Sinai Medical Center, Los Angeles, CA, USA

4. Department of Urology, University of Southern California, Los Angeles, CA, USA

5. RAND Institute, Santa Monica, CA, USA

6. Department of Urology, University of California, San Diego, San Diego, CA, USA

7. Department of Medicine, Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA

8. Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA

9. Section of Urology, Durham VA Medical Center, Durham, NC, USA

10. Department of Medicine, Divisions of Gastroenterology and Health Services Research, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Abstract

Background Physician treatment preference may influence how risks are communicated in prostate cancer consultations. We identified persuasive language used when describing cancer prognosis, life expectancy, and side effects in relation to a physician’s recommendation for aggressive (surgery/radiation) or nonaggressive (active surveillance/watchful waiting) treatment. Methods A qualitative analysis was performed on transcribed treatment consultations of 40 men with low- and intermediate-risk prostate cancer across 10 multidisciplinary providers. Quotes pertaining to cancer prognosis, life expectancy, and side effects were randomized. Coders predicted physician treatment recommendations from isolated blinded quotes. Testing characteristics of consensus predictions against the physician’s treatment recommendation were reported. Coders then identified persuasive strategies favoring aggressive/nonaggressive treatment for each quote. Frequencies of persuasive strategies favoring aggressive/nonaggressive treatment were reported. Logistic regression quantified associations between persuasive strategies and physician treatment recommendations. Results A total of 496 quotes about cancer prognosis ( n = 127), life expectancy ( n = 51), and side effects ( n = 318) were identified. The accuracy of predicting treatment recommendation based on individual quotes containing persuasive language ( n = 256/496, 52%) was 91%. When favoring aggressive treatment, persuasive language downplayed side effect risks and amplified cancer risk (recurrence, progression, or mortality). Significant predictors ( P < 0.05) of aggressive treatment recommendation included favorable side effect interpretation, downplaying side effects, and long time horizon for cancer risk due to longevity. When favoring nonaggressive treatment, persuasive language amplified side effect risks and downplayed cancer risk. Significant predictors of nonaggressive treatment recommendation included unfavorable side effect interpretation, favorable interpretation of cancer risk, and short time horizon for cancer risk due to longevity. Conclusions Physicians use persuasive language favoring their preferred treatment, regardless of whether their recommendation is appropriate. Implications Clinicians should quantify risk so patients can judge potential harm without solely relying on persuasive language. Highlights Physicians use persuasive language favoring their treatment recommendation when communicating risks of prostate cancer treatment, which may influence a patient’s treatment choice. Coders predicted physician treatment recommendations based on isolated, randomized quotes about cancer prognosis, life expectancy, and side effects with 91% accuracy. Qualitative analysis revealed that when favoring nonaggressive treatment, physicians used persuasive language that amplified side effect risks and downplayed cancer risk. When favoring aggressive treatment, physicians did the opposite. Providers should be cognizant of using persuasive strategies and aim to provide quantified assessments of risk that are jointly interpreted with the patient so that patients can make evidence-based conclusions regarding risks without solely relying on persuasive language.

Funder

national cancer institute

Publisher

SAGE Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3